Highly Expandable Human iPS Cell–Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High‐Throughput Screening
Current Protocols in Human Genetics · 2017-01 · 92 (1)
DOI: 10.1002/cphg.33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols in Human Genetics, online erschienen am 11.01.2017. Verfasst von Chialin Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Neurobiology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Cell Differentiation, High-Throughput Screening Assays, Models, Biological. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIMH NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Reprogramming of human somatic cells into induced pluripotent stem (iPS) cells has greatly expanded the set of research tools available to investigate the molecular and cellular mechanisms underlying central nervous system (CNS) disorders. Realizing the promise of iPS cell technology for the identification of novel therapeutic targets and for high‐throughput drug screening requires implementation of methods for the large‐scale production of defined CNS cell types. Here we describe a protocol for generating stable, highly expandable, iPS cell–derived CNS neural progenitor cells (NPC) using multi‐dimensional fluorescence activated cell sorting (FACS) to purify NPC defined by cell surface markers. In addition, we describe a rapid, efficient, and reproducible method for generating excitatory cortical‐like neurons from these NPC through inducible expression of the pro‐neural transcription factor Neurogenin 2 (iNgn2‐NPC). Finally, we describe methodology for the use of iNgn2‐NPC for probing human neuroplasticity and mechanisms underlying CNS disorders using high‐content, single‐cell‐level automated microscopy assays. © 2017 by John Wiley & Sons, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Neurobiology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
- Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
- Harvard Stem Cell Institute and Center for Regenerative Medicine Flow Cytometry Core Facility, Massachusetts General Hospital, Boston, Massachusetts.
- Currently at FACS & Imaging Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany.
Förderung
- NINDS NIH HHS
- NIMH NIH HHS
- NIA NIH HHS
Zitieren
APA
Cheng, C., Fass, D. M., Folz-Donahue, K., MacDonald, M. E., & Haggarty, S. J. (2017). Highly Expandable Human iPS Cell–Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High‐Throughput Screening. Current Protocols in Human Genetics, 92(1). https://doi.org/10.1002/cphg.33
Vancouver
Cheng C, Fass DM, Folz-Donahue K, MacDonald ME, Haggarty SJ. Highly Expandable Human iPS Cell–Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High‐Throughput Screening. Current Protocols in Human Genetics. 2017;92(1). doi:10.1002/cphg.33
BibTeX
@article{Cheng2017,
author = {Cheng, Chialin and Fass, Daniel M and Folz-Donahue, Kat and MacDonald, Marcy E and Haggarty, Stephen J},
title = {Highly Expandable Human iPS Cell–Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High‐Throughput Screening},
journal = {Current Protocols in Human Genetics},
year = {2017},
volume = {92},
number = {1},
doi = {10.1002/cphg.33}
}
EUVIMED